Friday, 11 November 2022

Bayer acquires German Biotech Start-up Targenomix

Bayer acquires German Biotech Start-up Targenomix
Bayer acquires German Biotech Start-up Targenomix

Bayer announced the acquisition of German biotech start-up Targenomix. The spin-off of the Max Planck Institute for Molecular Plant Physiology (MPI MPP) uses novel systems biology and computational life science tools to identify new modes of action for crop protection compounds.

admin Fri, 11/11/2022 - 16:42

source https://www.pharmatutor.org/pharma-news/2022/bayer-acquires-german-biotech-start-up-targenomix

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...